Madrigal Pharmaceuticals
MDGL
#2088
Rank
โ‚ฌ8.02 B
Marketcap
345,59ย โ‚ฌ
Share price
-4.45%
Change (1 day)
-27.37%
Change (1 year)

Earnings for Madrigal Pharmaceuticals (MDGL)

Earnings in 2026 (TTM): -โ‚ฌ0.11 Billion

According to Madrigal Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ1.42 Billion. In 2025 the company made an earning of -โ‚ฌ0.25 Billion, an increase over its 2024 earnings that were of -โ‚ฌ0.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Madrigal Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.11 Billion-56.56%
2025 -โ‚ฌ0.25 Billion-41.05%
2024 -โ‚ฌ0.42 Billion25.02%
2023 -โ‚ฌ0.33 Billion23.86%
2022 -โ‚ฌ0.27 Billion20.24%
2021 -โ‚ฌ0.23 Billion17.25%
2020 -โ‚ฌ0.19 Billion117.61%
2019 -โ‚ฌ86.58 Million189.45%
2018 -โ‚ฌ29.92 Million3.85%
2017 -โ‚ฌ28.81 Million25.71%
2016 -โ‚ฌ22.92 Million-50.81%
2015 -โ‚ฌ46.58 Million-39.14%
2014 -โ‚ฌ76.53 Million-4.12%
2013 -โ‚ฌ79.82 Million
2011 -โ‚ฌ41.42 Million23.13%
2010 -โ‚ฌ33.64 Million-145.81%
2009 โ‚ฌ73.42 M-185.95%
2008 -โ‚ฌ85.43 Million41.52%
2007 -โ‚ฌ60.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚ฌ0.15 Billion 29.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚ฌ16.56 Million-85.28%๐Ÿ‡บ๐Ÿ‡ธ USA